InvestorsHub Logo

kayak_wench

08/17/23 9:59 AM

#384931 RE: jour_trader #384929

The deal prior was for drug with Loxapine. The fact that you comparing having Amphetamine ER (1.5 Billion market) license to Loxapine (5 million market) reveals you are a poor investor, biased, or both.